627 related articles for article (PubMed ID: 31567063)
1. Ebola Virus: Pathogenesis and Countermeasure Development.
Furuyama W; Marzi A
Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
[TBL] [Abstract][Full Text] [Related]
2. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
3. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
4. [Recent Advances in Vaccines and Drugs Against the Ebola Virus].
Zhu X; Yao C; Wei Y; Kou Z; Hu K
Bing Du Xue Bao; 2015 May; 31(3):287-92. PubMed ID: 26470536
[TBL] [Abstract][Full Text] [Related]
5. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():1803. PubMed ID: 30147687
[TBL] [Abstract][Full Text] [Related]
6. Progress towards a vaccine against Ebola to meet emergency medical countermeasure needs.
Wolfe DN; Zarrabian AG; Disbrow GL; Espeland EM
Vaccine; 2019 Nov; 37(48):7178-7182. PubMed ID: 29199040
[TBL] [Abstract][Full Text] [Related]
7. EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.
Marzi A; Robertson SJ; Haddock E; Feldmann F; Hanley PW; Scott DP; Strong JE; Kobinger G; Best SM; Feldmann H
Science; 2015 Aug; 349(6249):739-42. PubMed ID: 26249231
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the development of vaccines for Ebola virus disease.
Ohimain EI
Virus Res; 2016 Jan; 211():174-85. PubMed ID: 26596227
[TBL] [Abstract][Full Text] [Related]
9. Considerations for use of Ebola vaccine during an emergency response.
Walldorf JA; Cloessner EA; Hyde TB; MacNeil A;
Vaccine; 2019 Nov; 37(48):7190-7200. PubMed ID: 28890191
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vesicular stomatitis virus expressing Ebola virus glycoprotein (rVSV-EBOV), a new Ebola vaccine.
Kasereka MC; Mumtaz Z; Hawkes MT
Drugs Today (Barc); 2021 Jan; 57(1):27-45. PubMed ID: 33594388
[TBL] [Abstract][Full Text] [Related]
11. From bench to almost bedside: the long road to a licensed Ebola virus vaccine.
Wong G; Mendoza EJ; Plummer FA; Gao GF; Kobinger GP; Qiu X
Expert Opin Biol Ther; 2018 Feb; 18(2):159-173. PubMed ID: 29148858
[TBL] [Abstract][Full Text] [Related]
12. Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
Anderson MS; Niemuth NA; Sabourin CL; Badorrek CS; Bounds CE; Rudge TL
PLoS One; 2020; 15(8):e0238196. PubMed ID: 32841291
[TBL] [Abstract][Full Text] [Related]
13. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
Mendoza EJ; Qiu X; Kobinger GP
Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
[TBL] [Abstract][Full Text] [Related]
14. The potential impact of a prophylactic vaccine for Ebola in Sierra Leone.
Bodine EN; Cook C; Shorten M
Math Biosci Eng; 2018 Apr; 15(2):337-359. PubMed ID: 29161839
[TBL] [Abstract][Full Text] [Related]
15. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
16. Ebola and Marburg virus vaccines.
Reynolds P; Marzi A
Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
18. Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention.
Nicastri E; Kobinger G; Vairo F; Montaldo C; Mboera LEG; Ansunama R; Zumla A; Ippolito G
Infect Dis Clin North Am; 2019 Dec; 33(4):953-976. PubMed ID: 31668200
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiological situation of Ebola virus disease in West Africa].
Arima Y; Shimada T
Uirusu; 2015; 65(1):47-54. PubMed ID: 26923957
[TBL] [Abstract][Full Text] [Related]
20. The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms.
O'Donnell K; Marzi A
Expert Rev Vaccines; 2020 Mar; 19(3):267-277. PubMed ID: 32129120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
